J Todd Belcik1, Brian P Davidson1, Ted Foster1, Yue Qi1, Yan Zhao1, Dawn Peters1, Jonathan R Lindner2. 1. From the Knight Cardiovascular Institute (J.T.B., B.P.D., T.F., Y.Q., Y.Z., J.R.L.) and Department of Public Health and Preventative Medicine (D.P.), Oregon Health & Science University, Portland. 2. From the Knight Cardiovascular Institute (J.T.B., B.P.D., T.F., Y.Q., Y.Z., J.R.L.) and Department of Public Health and Preventative Medicine (D.P.), Oregon Health & Science University, Portland. linderj@ohsu.edu.
Abstract
BACKGROUND: In diabetes mellitus, reduced perfusion and capillary surface area in skeletal muscle, which is a major glucose storage site, contribute to abnormal glucose homeostasis. Using contrast-enhanced ultrasound, we investigated whether abdominal adipose tissue perfusion is abnormal in insulin resistance and correlates with glycemic control. METHODS AND RESULTS: Contrast-enhanced ultrasound perfusion imaging of abdominal adipose tissue and skeletal muscle was performed in obese insulin resistance (db/db) mice at 11 to 12 or 14 to 16 weeks of age and in control lean mice. Time-intensity data were analyzed to quantify microvascular blood flow (MBF) and capillary blood volume (CBV). Blood glucose response for 1 hour was measured after insulin challenge (1 U/kg, IP). Compared with control mice, db/db mice at 11 to 12 and 14 to 16 weeks had a higher glucose concentration area under the curve after insulin (11.8±2.8, 20.6±4.3, and 28.4±5.9 mg·min/dL [×1000], respectively; P=0.0002) and also had lower adipose MBF (0.094±0.038, 0.035±0.010, and 0.023±0.01 mL/min per gram; P=0.0002) and CBV (1.6±0.6, 1.0±0.3, and 0.5±0.1 mL/100 g; P=0.0017). The glucose area under the curve correlated in a nonlinear fashion with both adipose and skeletal muscle MBF and CBV. There were significant linear correlations between adipose and muscle MBF (r=0.81) and CBV (r=0.66). Adipocyte cell volume on histology was 25-fold higher in 14- to 16-week db/db versus control mice. CONCLUSIONS: Abnormal adipose MBF and CBV in insulin resistance can be detected by contrast-enhanced ultrasound and correlates with the degree of impairment in glucose storage. Abnormalities in adipose tissue and muscle seem to be coupled. Impaired adipose tissue perfusion is in part explained by an increase in adipocyte size without proportional vascular response.
BACKGROUND: In diabetes mellitus, reduced perfusion and capillary surface area in skeletal muscle, which is a major glucose storage site, contribute to abnormal glucose homeostasis. Using contrast-enhanced ultrasound, we investigated whether abdominal adipose tissue perfusion is abnormal in insulin resistance and correlates with glycemic control. METHODS AND RESULTS: Contrast-enhanced ultrasound perfusion imaging of abdominal adipose tissue and skeletal muscle was performed in obese insulin resistance (db/db) mice at 11 to 12 or 14 to 16 weeks of age and in control lean mice. Time-intensity data were analyzed to quantify microvascular blood flow (MBF) and capillary blood volume (CBV). Blood glucose response for 1 hour was measured after insulin challenge (1 U/kg, IP). Compared with control mice, db/db mice at 11 to 12 and 14 to 16 weeks had a higher glucose concentration area under the curve after insulin (11.8±2.8, 20.6±4.3, and 28.4±5.9 mg·min/dL [×1000], respectively; P=0.0002) and also had lower adipose MBF (0.094±0.038, 0.035±0.010, and 0.023±0.01 mL/min per gram; P=0.0002) and CBV (1.6±0.6, 1.0±0.3, and 0.5±0.1 mL/100 g; P=0.0017). The glucose area under the curve correlated in a nonlinear fashion with both adipose and skeletal muscle MBF and CBV. There were significant linear correlations between adipose and muscle MBF (r=0.81) and CBV (r=0.66). Adipocyte cell volume on histology was 25-fold higher in 14- to 16-week db/db versus control mice. CONCLUSIONS:Abnormal adipose MBF and CBV in insulin resistance can be detected by contrast-enhanced ultrasound and correlates with the degree of impairment in glucose storage. Abnormalities in adipose tissue and muscle seem to be coupled. Impaired adipose tissue perfusion is in part explained by an increase in adipocyte size without proportional vascular response.
Authors: Lucy H Clerk; Michelle A Vincent; Linda A Jahn; Zhenqi Liu; Jonathan R Lindner; Eugene J Barrett Journal: Diabetes Date: 2006-05 Impact factor: 9.461
Authors: Kirsi A Virtanen; Peter Lönnroth; Riitta Parkkola; Pauliina Peltoniemi; Markku Asola; Tapio Viljanen; Tuula Tolvanen; Juhani Knuuti; Tapani Rönnemaa; Risto Huupponen; Pirjo Nuutila Journal: J Clin Endocrinol Metab Date: 2002-08 Impact factor: 5.958
Authors: Fredrik Karpe; Barbara A Fielding; Vera Ilic; Ian A Macdonald; Lucinda K M Summers; Keith N Frayn Journal: Diabetes Date: 2002-08 Impact factor: 9.461
Authors: Marco Pascotto; Howard Leong-Poi; Beat Kaufmann; Achim Allrogen; Dimitrios Charalampidis; Edmund K Kerut; Sanjiv Kaul; Jonathan R Lindner Journal: J Am Soc Echocardiogr Date: 2007-06-12 Impact factor: 5.251
Authors: Matthew A Muller; Aris Xie; Yue Qi; Yan Zhao; Koya Ozawa; Misty Noble-Vranish; Jonathan R Lindner Journal: Ultrasound Med Biol Date: 2020-06-08 Impact factor: 2.998
Authors: O'Neil R Mason; Brian P Davidson; Paul Sheeran; Matthew Muller; James M Hodovan; Jonathan Sutton; Jeffry Powers; Jonathan R Lindner Journal: JACC Cardiovasc Imaging Date: 2019-08-14
Authors: Matthew A Muller; James Hodovan; Koya Ozawa; Matthew W Hagen; Theodore R Hobbs; John Templon; Yan Zhao; John A Kaufman; Jonathan R Lindner Journal: Ultrasound Med Biol Date: 2022-08-05 Impact factor: 3.694
Authors: Matthew A Muller; Koya Ozawa; James Hodovan; Matthew W Hagen; David S H Giraud; Yue Qi; Aris Xie; Theodore R Hobbs; Paul S Sheeran; Jonathan R Lindner Journal: Ultrasound Med Biol Date: 2021-04-29 Impact factor: 3.694
Authors: Lance A Johnson; Kristen L Zuloaga; Tara L Kugelman; Kevin S Mader; Jeff T Morré; Damian G Zuloaga; Sydney Weber; Tessa Marzulla; Amelia Mulford; Dana Button; Jonathan R Lindner; Nabil J Alkayed; Jan F Stevens; Jacob Raber Journal: EBioMedicine Date: 2015-12-12 Impact factor: 8.143
Authors: Pratiek N Matkar; Krishna Kumar Singh; Dmitriy Rudenko; Yu Jin Kim; Michael A Kuliszewski; Gerald J Prud'homme; David W Hedley; Howard Leong-Poi Journal: Oncotarget Date: 2016-10-25